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Abstract
Polyphenols are naturally occurring compounds that are
found within numerous plant sources. They have a wide variety of structures and functions and have potential clinical
uses in multiple disease states. Emerging studies involving
polyphenols have demonstrated their antioxidative properties, as well as reduced risks of cardiovascular diseases and
certain types of cancer. Due to these discoveries, there has
been a marked increase in research related to the chemical
properties of polyphenols and their potential uses in prevention of common acquired and inherited disease states. This
article focuses on the effects that some polyphenolic compounds exert on immune function in regard to the induction
and clinical manifestations of the allergic response and how
supplementation with polyphenol-enriched apple extracts
may alter the approach to treating atopic dermatitis and food
allergies. Currently, due to the lack of large clinical trials detailing efficacy and safety data for these compounds when
used to alter immune system responses to allergens, there
are no strong recommendations for their use as prevention
or acute treatment strategies for allergies.
Introduction
Researchers have been searching for natural products that
are able to influence immune responses in regard to allergic
disorders. Dietary polyphenols have been identified in multiple preclinical and a limited number of human trials as having the potential to alter the body's sensitivity to allergens
and treat the allergic symptoms.1,2 These compounds have
been extensively researched in the past for many other conditions due to their anti-inflammatory and antioxidant properties, but the true connection to allergic disorders is still
unclear. Polyphenols have shown benefits in studies focusing
on animal models by having activity at the sensitization stage
and during re-exposure to an allergen.
Most available therapies focus on treating allergy symptoms
and not on the prevention or moderation of the allergic reaction. Current clinical recommendations for the treatment of
symptoms associated with allergies include oral and topical
antihistamines, corticosteroids, anticholinergics and mast
cell stabilizers, which all focus on reducing the severity of the
immune response and are relatively effective at doing so.3,4
However, these medications should not be used long-term or
in excessive doses due to an increased risk in associated adverse effects. For instance, long-term use of topical corticosteroids can cause side effects ranging from local skin atrophy
to the development of Cushing's syndrome.s Also, although
uncommon, overuse of antihistamines can result in adverse
events as serious as QT prolongation and cardiac arrhythmias due to the drugs' inverse agonist activity at the Histamine 1 receptor (H1).6 It is clear that there is a need for a

therapeutic option that can effectively treat symptoms, as
well as decrease the overall frequency of outbreaks by
changing sensitivity to an allergen.
Allergic Immune Response
The exact mechanism of an immune response, while varied
and specific for a particular allergen, generally revolves
around the synthesis and resulting activity of inflammatory
mediators, such as cytokines and interleukins that are produced by activated T helper (TH) cells of the adaptive immune system.7 These cells communicate with each other and
with other cells of the immune system through the timed
release of chemical mediators. These mediators' further activation of immune processes focuses on the isolation, destruction and removal of a "non-self' substance in order to avoid
potentially adverse insults and to regulate normal internal
homeostasis. TH cells involved in this process are broken
down and classified into two subcategories based upon cytokine production, through which subsequent immune cell
types are activated and the specific protective outcome induced. Ttt1 cells stimulate a nonspecific cellular immune response through the secretion of interferon gamma (IFN-y)
that activates innate immune system mediators including
monocytes, tissue macrophages and natural killer (NK) cells.
lFN-y can also stimulate cytotoxic T-lymphocytes (Tc cells),
as well as activate inducible nitric oxide synthase (iNOS) to
produce nitric oxide (NO) free radicals in order to directly
target bacteria and protozoa. Ttt2 cells focus on stimulating
the production of adaptive immune cells, B lymphocytes, basophils and eosinophils, in addition to up-regulating antigenspecific antibodies, which regulate humoral immunity.7.a
Other cell types that are activated by this response include
lmmunoglobulin E (IgE), which stimulates mast cells to release histamine, serotonin and leukotrienes in order to cause
bronchoconstriction. Optimal immune function relies on a
dynamic balance between the two processes to effectively
eradicate any foreign threat that is detected. Exaggerated
allergic responses become problematic when there is an imbalance between TH1 and TH2 immunity, causing an overproduction ofTH2 pathway products.
An allergic disorder develops when the immune system detects a harmless allergen, considers it a threat and mounts
local and systemic responses through Ttt2 cell activity.1 The
immune response to the initial allergen exposure not only
works to rid the body of the foreign contaminate through
innate immune function, but will additionally sensitize the
adaptive immune system to recognize the particular allergen
more readily upon re-exposure.9 This is accomplished
through the production of antigen-specific IgE by plasma
cells matured from activated B lymphocytes in response to
the cytokines produced by Ttt2 cells, most notably inter-
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leukin 4 (IL-4).9,10 Binding of these antigen-specific lgE molecules to the reintroduced allergen will cause symptoms of
acute phase, as well as late phase immune reactions, due to
the degranulation of mast cells. Inflammatory mediators released from these mast cells (histamine, interleukins and
prostaglandins) can enhance vascular leakage while
chemoattractants recruit basophils and eosinophils, as well
as leukocytes in later stages, to the area of allergic reaction.
Other cytokines cause upregulation of adhesion molecules
for these leukocytes on vascular endothelial surfaces, which
is critical for the progression to late phase reactions and
chronic inflammation in future allergic reactions.1.2.9.10
In regard to specific types of allergic responses, food allergies
can begin to develop during infancy after ingestion of an allergy-provoking food, but throughout life environmental factors can trigger respiratory allergies or skin allergies such as
atopic dermatitis. Allergic reactions can also occur in part
due to a genetic predisposition, called atopic syndrome
(atopy).11 This increased reactivity is characterized by the
preferential production of IgE in response to allergens whose
clinical manifestations may include atopic dermatitis, allergic
contact urticaria, dyshidrotic eczema, allergic rhinitis,
asthma, conjunctivitis, gastrointestinal allergies or any combination of the above. 11 An important diagnostic criteria of
atopic syndrome is the production of allergen-specific IgE.
Gene polymorphisms critical for the development of atopic
syndrome are involved in the regulation of the TH1/TH2 ratio.
Upon exposure to a specific allergen in a patient with atopy,
the ratio skews toward a predominantly TH2 cell response
and the corresponding cytokine production. An overactivation of TH2 lymphocytes against these presented antigens
will cause a type I IgE-mediated allergy and hypersensitivity.
More recently, alterations in genes for mast cell chymase
(found only in dermal mast cells), and the a and~ chains for
the IgE receptor (representing a "gain of function" allele)
have also been implicated in the preferential production of
Ttt2 cells and their respective cytokines.11
Polyphenol Chemistry
Polyphenols are naturally occurring and biologically active
chemicals that are found in a variety of fruits (apples and
grapes), plants (vegetables and legumes) and drinks (wine,
cider, beer and tea) that are part of the human diet. They are
considered nonnutrients because they are not required for
normal body functions such as growth and development.12
Polyphenolic compounds are byproducts of major metabolic
pathways in plants and are extremely diverse in their chemical presentation. Currently, over 8,000 polyphenols have
been identified, contributing significantly to the varied structures and bioactivity in plants and humans.13 The highest
concentrations of polyphenols are found in the parts of the
plant source that are highly exposed to light, especially the
leaves. Lower concentrations of polyphenols are found in
portions of the plant that are underground, such as the tubers and roots.
Polyphenols have been considered deleterious to health due
to their ability to bind to and precipitate proteins and other
macromolecules, altering protein and macronutrient diges-
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tion and absorption from the gastrointestinal tract, as well as
altering gut physiology (pH, colonic flora, biliary excretion,
transit time, etc.). 14 Results of more recent studies have indicated that these interactions may also interfere with the
bioavailability of polyphenols although the exact interaction
remains undetermined. Renewal of interest in polyphenols,
especially flavonoids, has been due to their proven antioxidant effects as free radical scavengers, Vitamin C and E regenerators and inhibitors of low density lipoprotein (LDL)
oxidation. These properties have prompted research about
other potential health benefits that these compounds may
provide, including their potential use in altering immune response to allergic processes. 13 One of the most wellrenowned types of polyphenols, the flavonoids, have displayed some medicinal applications in disease states including hypertension, allergies and hypercholesterolemia, and
also as anti-inflammatory agents, anti-ulceratives, antibiotics
and antidiarrheals.13
The overall structure of polyphenols is defined by the presence of one or more hydroxyl groups attached to aromatic
rings.i.12 Additional chemical and structural classifications of
polyphenols divide this broad class of molecules into at least
10 subclasses depending on numerous factors including
structural complexity, the presence of conjugated sugar
groups, as well as other heteroatom linkages such as carboxylic acids, amines and phenols that alter the basic chemical
structure.13 The most basic classifications of polyphenols can
be made into the following four groups: flavonoids, phenolic
acids, stilbenes and lignans. Flavonoids and phenolic acids
are the most abundant classes of polyphenols found in the
human diet and can be further categorized based upon the
location of hydroxyl groups. Flavonoids, with subclasses of
flavones, isoflavones, flavanones, flavanols, flavonols and
flavan-3-ols, are naturally abundant and are the basic building blocks of more complex polyphenols such as tannins
which are highly hydrolyzed compounds capable of forming
insoluble deposits with proteins.13
Polyphenols and Atopic Dermatitis
The possible anti-allergic effects of polyphenols have
sparked studies looking at the potential benefits that supplementation could bring to patients suffering from skin allergies such as atopic dermatitis. Within the Atopy Outpatient
Clinic of Kojima Hospital located in Tokyo, Japan, researchers
examined the impact of apple extract supplementation on
patients with atopic dermatitis.15 Apple condensed tannins
(ACT) were extracted from unripe apples and formulated
into an oral dosage. Condensed tannins, also referred to as
proanthocyanidin, are built from the flavan-3-ol class ofpolyphenols and have comparatively high molecular weights.12
Previous studies in animal models had predicted that tannins
are able to inhibit histamine release from mast cells and basophils, but this pilot study aimed to determine if ACTs are
effective in human subjects as welJ.15 Twenty-four patients
between the ages of 8 and 18 years suffering from atopic dermatitis were selected for participation in the study, and then
randomly divided into treatment or standard treatment control groups. Groups were determined to be comparable in
regard to gender, age, peripheral eosinophil levels, and se-
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rum IgE levels. Initially, both groups of patients began a standardized treatment using bufexamac ointment, half doses of
alclometasone dipropionate ointment and hydroxyzine hydrochloride tablets (strengths and doses of medications not
specified), which would be continued throughout the study
period. Two weeks into the study, the treatment group added
the ACT supplement to the regimen, dosed at 10 mg/kg divided into two daily doses. At the end of the ten-week study,
the severity of the atopic dermatitis was assessed using a
scoring system. The severity of each of the following was
rated on a scale of zero to two: inflammation, cracking and
hardening of the skin. Each location on the body, defined as
trunk, arms, legs and face, counted as a separate score. Itching and sleep disturbances were also evaluated using a scale
of zero to three. Total scores greater than 21 points were
classified as severe. Starting and ending levels of serum IgE,
peripheral eosinophils, glutamic oxaloacetic transaminase
(GOT) and glutamic pyruvic transaminase (GPT) were also
obtained from each patient. IgE and eosinophil counts were
used to measure the change in the immune response with
treatment; whereas, GOT and GPT values acted as nonspecific indicators of inflammation and tissue damage that are
often elevated in dermatitis cases.
Patients receiving the ACT treatment showed a decrease in
dermatitis scores overall (amount of decrease not specified),
especially in the categories of itching and sleep disturbance.is Also in the treatment group, a statistically significant
decrease was seen in peripheral eosinophil levels
(525 versus 760/µL at baseline; p<0.01), but there was no
significant difference in these levels within the control group
(673 versus 784/µL at baseline). Neither group showed a
significant difference in IgE, GOT and GPT levels. The study
concluded that ACT supplementation may be effective at decreasing atopic dermatitis when used in combination with
standard treatment with no significant side effects. This
study was only performed to gather baseline data on the use
of apple extract supplements in the treatment of atopic dermatitis. In summary, results were positive regarding the improvement in allergic symptoms, but additional studies using
a larger patient population are needed to assess symptom
management and the possibility of an ACT effect on the sensitization stage of allergic disorders.
Polyphenols and Food Allergies
The research regarding the anti-allergic effects of polyphenol
research has extended beyond skin allergies to examine the
potential impact on food allergies. Researchers in Switzerland studied the use of apple extracts for the reduction of
food allergy symptoms in mice.16 The apple extracts chosen
for the trial had been enriched with polyphenols, mainly flavonols. To begin, all mice were sensitized to the allergen
ovalbumin (OVA), the main protein found in egg, using
weekly doses of 20 mg. As an adjuvant, 10 µg of Cholera toxin
(CT) was also given to the mice to ensure sensitivity to the
allergen would develop during the seven weeks under study.
Previous studies have found CT to stimulate long-term immunological memory, particularly in the gut mucosa.17 At the
same time, mice were divided into four groups. 16 One group
received the apple extract (1 % weight-in-weight) in their

food pellets during the sensitization process, and another
group started the apple extract in the final week of the sensitization process which was used to detect secondary prevention. The study used two controls; the positive control group
was not treated with the apple extract, and the negative control group was only sensitized to CT and not OVA. At the end
of the seven weeks, the mice were given a challenge to the
newly sensitized allergen using 100 mg OVA. Allergic reactions in the mice were observed for 30 minutes and scores
were recorded based on the severity and frequency of symptoms including scratching, bristled fur, diarrhea, labored respiration and anaphylaxis. Blood, lymph node and intestine
samples were then obtained from the animal subjects.
Results of the study were generally positive in concern to the
benefits of polyphenol-enriched apple extracts. As expected,
the negative control group did not experience any symptoms
upon challenge to the antigen. Mice who received the apple
extract during the final week of sensitization to test the secondary prevention hypothesis had significantly lower observation scores for symptoms. However, the mice ingesting the
apple extract throughout the entire sensitization period did
not experience fewer symptoms compared to the positive
control group, which may show that polyphenols cannot prevent the development of an allergic response. Serum IgE levels were not found to vary in any of the mice regardless of
apple extract treatment, but lower levels of cytokines were
released from lymph nodes in the treated population of mice.
A protease from intestinal mast cells, known to be involved
in allergic responses to food allergens, was found in lower
concentrations only in the secondary treatment group, which
suggests an inhibition of the effector cell. Researchers tested
the hypothesis that polyphenols may bind to proteins and
lead to a diminished immune response. In vitro experiments
showed that macro-complexes formed between the apple
extract and OVA, resulting in decreased antibody reactivity.
Contrary to expectation, in mice receiving the apple extract
in their food pellets throughout the entire sensitization process, the apple extract provided no benefit as a primary prevention mechanism.
Conclusion
Although common in dietary sources, polyphenols are often
used as a supplement and are available as an extract that has
been formulated into an oral dosage. A variety of natural
polyphenol products are available over the counter, and
pharmacists must be knowledgeable about the current options and safety information for proper patient counseling.
Supplements on the store shelf may be labeled as tablets or
capsules containing polyphenols in general or may specify a
particular category of polyphenols such as flavonoids. Polyphenol-containing compounds are marketed mainly for their
antioxidant properties. It is expected that extracts from fruits
or plants act as the main ingredients in these products. Some
of the most common polyphenol products purchased by patients include green tea, grape, berry or apple extracts.
Because of the limited number of human trials that have
been conducted, proper dosing of polyphenol supplements is
still unknown. Bioavailability of oral preparations of these

Evidence for the Potential Use of Polyphenols and their Derivatives in Moderating Allergic Immune Responses

compounds is relatively low and dependent on the size of the
chemical structure, which varies greatly between the subclasses.12 Dosing becomes a balance of finding a high enough
dose to cause the intended effect, such as decreasing allergic
symptoms, but not causing adverse reactions due to excessive intake. For instance, high concentrations of polyphenols
have been found to cause decreased viability of liver cells,
interruption of cell signaling cascades and auto-oxidation
processes within cells.12
Additional research is still necessary to fully determine
bioavailability, optimal dosing, and overall safety of
polyphenolic compounds in human subjects. The ability of
polyphenol supplementation to alter the body's sensitivity to
allergens and to treat allergic symptoms is still under investigation. Although it seems certain these compounds exhibit
chemical mechanisms that may justify their therapeutic use
in allergic responses, adequate scientific trials in large patient populations are not yet available. As pharmacists, it is
important to educate patients on the risks associated with
taking excessive doses of polyphenol supplements. However,
difficulties in designing dosing regimen strategies may arise
due to limited research data on the levels necessary to
achieve a clinically significant effect and also due to the large
variety of polyphenolic compounds available for use. Despite
the promising potential for the use of polyphenol-containing
products in the moderation of allergic immune responses,
polyphenol supplements should not be recommended as an
effective option for allergy purposes until further research is
conducted.
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